success stories

Alpha-Beta Technology, Inc.

Acquisition

Alpha-Beta was the second ever startup company to enter the MBI incubator. Alpha-Beta reached a peak headcount of 220 employees and peak market capitalization of $350 million, before being sold in 1999. Products developed by Alpha-Beta are now marketed as Wellmune by Kerry, a global health and nutrition company.

Antigen Express, Inc

Acquired by Generex

Avatar Pharmaceuticals

Acquired by Vertex Pharmaceuticals

Biocytogen, LLC

IPO, $335M+

Bioflash Partners, LLC

Acquired by Repligen

Biomere

Acquired by JOINN Laboratories Co. Ltd.

Blue Sky Biotech, Inc

Acquired by Curia

Coley Pharmaceutical Group, Inc

Acquired by Pfizer

Convergent Dental

$115M+ raised, commercialized product

HSRL, Inc.

Acquired by StageBio

Invetx

IPO, $80M+

iVexSol

Series A

Nyla Laboratories

Acquired

Tarpon Biosystems, Inc

Tech Acquisition by Pall

TransCode Therapeutics

IPO, $7M

ViaCell, Inc

Acquired by Perkin Elmer

Vivo Path LLC

Acquired by Charles River Laboratories

Yurogen Biosystems, LLC

Acquired by ABClonal Science Inc.